Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 18.2% during mid-day trading on Thursday . The company traded as high as C$0.20 and last traded at C$0.20. Approximately 134,894 shares traded hands during trading, a decline of 75% from the average daily volume of 530,731 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Price Performance
The stock has a market capitalization of C$27.89 million, a P/E ratio of -20.00 and a beta of 0.32. The business has a fifty day simple moving average of C$0.10 and a 200 day simple moving average of C$0.07. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- Are Penny Stocks a Good Fit for Your Portfolio?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
